Condition: Asthma in Children · Asthma Attack · Sponsor: University of Oklahoma
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.
This description comes directly from the study's public registry record.
Ryan McKee, MD · 4056308997 · ryan-mckee@ouhsc.edu
Jaclyn Urquiola Sorzano, DO · 7863906297 · jaclyn-urquiola@ouhsc.edu
Always discuss trial participation with your own doctor first.
| Oklahoma Children's Hospital | Oklahoma City, Oklahoma, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06137040